High Dose Vitamin C IV Cancer Therapy in London

Explore how our vitamin C IV therapy works in conjunction with conventional cancer treatments to improve your overall quality of life.

GMC-Registered Doctors

Research-Backed Protocols

Tailor Designed Approach

Trusted by Thousands

Vitamin C IV Cancer Therapy - London Clinic

Our Integrative Oncology Clinic has been carefully designed to provide High-Dose Vitamin C therapy specifically for the field of cancer care. As our expertise is focused solely in this area, we are not able to offer this treatment for non-cancer-related conditions.

By dedicating our efforts to one specialty, Wellbeing Medical Group aims to provide the most effective and supportive care for those diagnosed with cancer.

Experienced Team

Our IV infusion specialists are highly trained professionals with years of experience delivering safe, effective high-dose vitamin C therapy. We stay up to date with the latest clinical protocols to ensure optimal care and results.

London Location

Conveniently located in the heart of London, our clinic is easily accessible by public transport and major roads. We provide a central, discreet setting for premium wellness treatments.

Welcoming Environment

We’ve created a calm, modern space where your comfort and wellbeing come first. From the moment you arrive, our friendly team is here to make you feel relaxed and supported.

Flexible Appointments

We offer flexible scheduling to fit your busy lifestyle. Booking is simple and designed around your convenience.

ENQUIRE NOW

What Is Vitamin C IV Therapy?

Vitamin C IV therapy involves a professional administering a high dose of vitamin C through a vein and into your bloodstream. Using a vitamin C IV drip to administer the vitamin C allows for higher concentrations in the body that can’t be achieved with oral intake. Where oral intake can result in just 10% absorption of vitamin C, IV therapy allows for the full 100% to be absorbed, resulting in greater benefits when used in conjunction with conventional cancer treatments.
High dose vitamin C infusion for cancer has shown potential to enhance immune function, improve patient wellbeing, sensitise tumours to chemotherapy and radiation and reduce tumour growth. Tumour growth reduction is particularly effective in tumours that have impaired antioxidant defence mechanisms.

LEARN MORE

Highly Qualified Team

Discover our medical team and explore how High‑Dose Vitamin C can support your health journey. Whether you’re seeking immune support, adjunctive cancer care, or recovery enhancement, our experienced clinicians are here to guide you with evidence-based IV therapy.

VIEW FULL TEAM

Add Team Image

Our Patients - Empowering People Lives

Fiona

Diagnosis: Adenocarcinoma non-small cell lung cancer

Fiona was diagnosed with non-small cell lung cancer with bone metastases. After completing one session of chemotherapy and immunotherapy, she chose to discontinue further treatment due to the side effects she experienced. Fiona’s objective was to supplement her conventional treatment with an integrative approach. To facilitate this, she promptly provided us with her biopsy results for review, allowing us to design a tailored plan of integrative therapies to support her care. Throughout therapies at Wellbeing Medical Group, she received regular scans from her oncologist, who closely monitored her progress and showed great compassion and care. Fiona was able to successfully achieve her goal of maintaining both quality of life and disease stability.

Graeme

Diagnosis: Adenocarcinoma Oesophagus

Graeme first reached out to Wellbeing Medical Group while awaiting his final biopsy results and diagnosis. Determined to explore both NHS and private pathways, he aimed to secure the best outcomes for his upcoming treatments and surgery.
We collaborated closely with Graeme to develop an integrative care plan tailored to his needs, aligning with his NHS treatment strategy. Graeme’s goals included enhancement of his overall well-being, creating an anti-cancer effect and support towards adverse reactions/side effects to hospital treatment pathways.

Isis

Diagnosis: Hodgkin Lymphoma

Isis approached Wellbeing Medical Group upon receiving her cancer diagnosis, with no conventional treatment having yet commenced. Due to the aggressive nature of her condition, she was about to begin a six-month chemotherapy regimen. Isis’ objective was to integrate complementary therapies alongside her chemotherapy, aiming to mitigate side effects and enhance the effectiveness of the chemotherapy. Given the advanced stage of her diagnosis, Wellbeing Medical Group recommended a more aggressive integrative approach. Isis committed to a comprehensive protocol that included the incorporation of additional anti-cancer therapies to maximize her outcomes throughout her chemotherapy journey. Isis also dedicated several months to expanding her knowledge by engaging with a range of academic literature and research materials.

SEE MORE PATIENT STORIES

Contact us for a free consultation.

Mon – Fri 9:00am – 6:00pm

185 Tower Bridge Road, London

020 3376 4835

info@wellbeingmedicalgroup.com

Why Choose High Dose IV Vitamin C For Cancer?

High dose vitamin C IV therapy is a key aspect of complementary cancer care. At high doses, vitamin C undergoes a transformation acting as a pro-oxidant. It’s this shift that plays the most crucial role in complementary cancer therapies by enhancing oxidative stress within cancer cells leading to cellular damage and promoting cancer cell death.
Unlike its typical role as an antioxidant, high dose vitamin C IV therapy can selectively target and damage cancer cells, whilst healthy cells remain unaffected.
The effectiveness of IV vitamin C for cancer is largely reliant on achieving a cumulative pro-oxidant effect, so a single dose will not provide you with the desired therapeutic outcomes. For maximum benefit, you should do repeat infusions over a set period as to maintain elevated levels of pro-oxidant activity and get maximum benefits.

High Dose Vitamin C IV Therapy FAQs

Are There Risks Associated With Vitamin C IV Therapy For Cancer?

When it comes to vitamin C IV therapy within cancer care, the benefits outweigh the risks, as intravenous vitamin C therapy has a very low risk of side effects.
As our patients merge their conventional route path with therapies such as high dose vitamin c, our medical team understands adverse reactions can be a results of treatments such as chemotherapy. All patients are monitored closely and with the use of high dose vitamin c alongside your conventional treatment, adverse reactions can subside over a shirt period of time.

How Does High Dose Vitamin C IV Therapy Work?

According to a range of scientific research[47], a fully competent immune system is required to maximise the antiproliferative effect of Vitamin C in breast, colorectal, melanoma, and pancreatic tumours. High-dose Vitamin C modulates infiltration of the tumour microenvironment via the cells of the immune system and delays cancer growth in a T cell-dependent manner.
Vitamin C not only enhances the cytotoxic activity of adoptively transferred CD8 T cells but also cooperates with immune checkpoint therapy (ICT) in several cancer types. A combination of this vitamin and ICT can be curative in models of mismatch repair-deficient tumours with a high mutational burden.
More literature [48] indicates that Vitamin C has the potential to be a potent anti-cancer agent when administered intravenously and in high doses (high-dose IVC). Early-phase clinical trials have confirmed the safety and indicated the efficacy of IVC in eradicating tumour cells of various cancer types.
High dose Vitamin C IV therapy has been shown to be safe and well-tolerated in cancer patients and has been scientifically proven to reduce pain and improve quality of life in the palliative care setting.

How Can High Dose Vitamin C IV Therapy Improve The Quality Of Life In Advance Cancer Cases?

In palliative care, high dose vitamin C IV therapy is currently gaining ground due to its highly safe and tolerable profile. Not only is high dose IV vitamin C therapy known to relieve pain in cancer patients [6], vast clinical evidence suggests that it has a significant positive impact on patients’ well-being [1, 2-5, 7-10]. This might be due to the frequent hypovitaminosis and Vitamin C deficiency in cancer patients [6, 11, 12], which are commonly enhanced by anti-neo-plastic treatments [3].
Research has shown that patients with radiotherapy-resistant bone metastasis have less pain and better performance measures when given high dose vitamin C IV therapy. Patients also had a median survival time of 10 months as compared to the 2-month median survival time within the control group [7].
Overall, high dose vitamin C IV therapy administered as a single agent has not only been shown to be safe and well-tolerated in cancer patients but also to alleviate pain and to improve quality of life in the palliative care setting.

Why Choose High Dose Vitamin C IV Therapy At Wellbeing Medical Group?

At Wellbeing Medical Group, we have specifically designed our high dose vitamin C IV therapy with the health of our patients in mind. We work alongside our patients to tailor your dosage to meet your unique medical needs and provide you with consistent support from start to finish.
Your comfort is our top priority, and we pride ourselves on having a calming environment during your therapy. We will help you relieve pain and manage the symptoms of cancer treatment using a range of complementary therapies administered by our expert cancer care consultants.
Contact our team today to find out more about how our high dose vitamin C IV therapy can help you and to book a consultation with our cancer care team.

How Does A Vitamin C IV Drip Work?

High dose vitamin C IV therapy works in a number of ways, and it can be incredibly beneficial when used alongside conventional cancer treatments. When you come to Wellbeing Medical Group for vitamin C IV therapy, you will work with one of our expert medical teams to receive a tailored vitamin C dosage to support your unique needs.
Whilst the exact anticancer mechanisms of IV vitamin C for cancer aren’t fully understood just yet, there have been a number of proposed mechanisms of action. These are some of the mechanisms of action for high dose vitamin C IV therapy in regards to cancer care.

Pro-oxidant Effects on Cancer Cells:

At high doses, Vitamin C transforms into a pro-oxidant, inducing oxidative stress by producing hydrogen peroxide within the tumour microenvironment. This oxidative damage is selectively more toxic to cancer cells than to healthy cells, which are better equipped to neutralise free radicals. This effect disrupts cancer cell metabolism and leads to cellular damage, including DNA fragmentation and mitochondrial dysfunction, which can trigger apoptosis (programmed cell death).

Sensitisation of Tumour Cells:

Vitamin C IV infusion has been shown to sensitise tumour cells to conventional cancer treatments such as chemotherapy and radiation therapy. By increasing oxidative stress in cancer cells, Vitamin C can enhance the cytotoxicity of these treatments, making them more effective while potentially reducing the risk of tumour resistance.

Immune System Support:

Vitamin C plays a critical role in immune function, supporting the production and activity of immune cells like T-cells, natural killer (NK) cells, and macrophages. High-dose Vitamin C IV infusions may enhance the body’s natural defence mechanisms against cancer and infections, improving patient outcomes, particularly during periods of immune suppression caused by cancer treatments.

Cumulative Effect and Repeat Dosing:

The effectiveness of high-dose Vitamin C IV infusion therapy is significantly enhanced when administered over a period of time. Cumulative dosing is essential to maintain elevated pro-oxidant levels in the body, ensuring sustained therapeutic effects. Vitamin C pro-oxidant action is most effective when levels are consistently elevated, making repeat dosing critical for optimal results.

National Coverage Available

Are you based outside of London seeking medical support with a complementary cancer care consultant?

Dedicated concierge service delivered to your home

Nationwide nursing support available

At-home intravenous infusion programme

GMC registered medical support

ENQUIRE NOW

The Benefits Of High Dose Vitamin C Therapy in London

There are a number of reasons individuals choose vitamin C IV administration rather than other mechanisms. Some of the benefits of choosing vitamin C IV therapy include:

Precise Dosing:

IV administration allows for precise dosing, which is crucial for achieving therapeutic effects while minimising potential side effects. Healthcare providers can adjust doses based on the patient’s specific needs and response to treatment.

Adjunct to Other Cancer Treatments:

Our IV infusion therapies can be used in combination with conventional cancer therapies such as chemotherapy, radiation, and immunotherapy. It has been shown to sensitise cancer cells to these treatments, potentially improving their efficacy and reducing the likelihood of drug resistance.

Higher Bioavailability:

This agent has limited bioavailability when taken orally due to its rapid metabolism and low absorption. IV infusion bypasses the digestive system, ensuring that higher concentrations of DCA are delivered directly into the bloodstream, leading to more effective therapeutic outcomes.

Faster Onset of Action:

Intravenous infusion provides rapid systemic distribution, allowing for quicker onset of therapeutic effects. This can be especially beneficial in patients undergoing active cancer treatment, where immediate metabolic reprogramming and enhanced tumour suppression are critical.

ENQUIRE NOW

Why Choose Wellbeing Medical Group for Vitamin C IV Therapy?

At Wellbeing Medical Group, we have specifically designed our vitamin C IV therapies with the health of our patients in mind. We work alongside you and your oncologist to tailor your dosage to meet your unique needs and provide you with consistent support from start to finish.
We make your comfort our top priority and we pride ourselves on having a calming environment during your vitamin C IV infusion. Contact our expert medical team today to find out more about how our high dose vitamin C IV therapy can help you.
We work alongside your cancer care team to ensure that our vitamin C IV infusions are working in conjunction with your conventional cancer treatments.

Are There Side Effects Of High Dose Vitamin C IV Therapy?

When it comes to vitamin C IV therapy, our team at Wellbeing Medical Group strongly believes the benefits outweigh the risks. However, there are a few unique situations where high dose vitamin C IV therapy is not recommended. This would be concluded by our lead medical consultant.
Our team of medical members can work alongside your cancer care team to discuss the possible risks and side effects before starting your vitamin C IV therapy. We check your complete medical history and the conventional cancer treatments you’re undergoing before embarking on any complementary therapies.

Research

1. Bryan Ngo et al, Targeting cancer vulnerabilities with high-dose vitamin C, Nat Rev Cancer 2019 May;19(5):271-282. doi: 10.1038/s41568-019-0135-7.
2. Polireddy K, Dong R, Reed G, Yu J, Chen P, Williamson S, et al. High dose parenteral Ascorbate inhibited pancreatic Cancer growth and metastasis: mechanisms and a phase I/IIa study. Sci Rep. 2017;7(1):17188.
3. Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, et al. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci. 2008;105(32):11105–9.
4. Schoenfeld JD, Sibenaller ZA, Mapuskar KA, Wagner BA, Cramer Morales KL, Furqan M, et al. O 2 ·− and H 2 O 2 Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate. Cancer Cell. 2017;31(4):487–500.e8.
5. Takahashi H, Mizuno H, Yanagisawa A. High dose intravenous vitamin C improves quality of life in cancer patients. Pers Med Universe. 2012;1(1):49–53.
6. Vollbracht C, Schneider B, Leendert V, Weiss G, Auerbach L, Beuth J. Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo−/radiotherapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study in Germany. In Vivo. 2011;25(6):983–90.
7. Yeom CH, Jung GC, Song KJ. Changes of terminal Cancer patients’ health‐related quality of life after high dose vitamin C administration. J Korean Med Sci. 2007;22(1):7.
8. Agathocleous M, Meacham CE, Burgess RJ, Piskounova E, Zhao Z, Crane GM, et al. Ascorbate regulates haematopoietic stem cell function and leukaemogenesis. Nature. 2017;549(7673):476–81.
9. Bonilla‐Porras AR, Jimenez‐Del‐Rio M, Velez‐Pardo C. Vitamin K3 and vitamin C alone or in combination induced apoptosis in leukemia cells by a similar oxidative stress signalling mechanism. Cancer Cell Int. 2011;11(1):19.
10. Cimmino L, Dolgalev I, Wang Y, Yoshimi A, Martin GH, Wang J, et al. Res‐ toration of TET2 Function Blocks Aberrant Self‐Renewal and Leukemia Progression. Cell. 2017;170(6):1079–1095.e20.
11. Iamsawat S, Tian L, Daenthanasanmak A, Wu Y, Nguyen HD, Bastian D, et al. Vitamin C stabilizes CD81 iTregs and enhances their therapeutic potential in controlling murine GVHD and leukemia relapse. Blood Adv. 2019;3(24):4187–201.
12. Mingay M, Chaturvedi A, Bilenky M, Cao Q, Jackson L, Hui T, et al. Vita‐ min C‐induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemia. Leukemia. 2018;32(1):11–20.
13. Aguilera O, Muñoz‐Sagastibelza M, Torrejón B, Borrero‐Palacios A, del Puerto‐Nevado L, Martínez‐Useros J, et al. Vitamin C uncouples the Warburg metabolic switch in KRAS mutant colon cancer. Oncotarget. 2016;7(30):47954–65.
14. Brandt KE, Falls KC, Schoenfeld JD, Rodman SN, Gu Z, Zhan F, et al. Augmentation of intracellular iron using iron sucrose enhances the toxicity of pharmacological ascorbate in colon cancer cells. Redox Biol. 2018;14(July 2017):82–7
15. Cenigaonandia‐Campillo A, Serna‐Blasco R, Gómez‐Ocabo L, Solanes‐ Casado S, Baños‐Herraiz N, Del Puerto‐ Nevado L, et al. Vitamin C activates pyruvate dehydrogenase (PDH) targeting the mitochondrial tricarboxylic acid (TCA) cycle in hypoxic KRAS mutant colon cancer. Theranostics. 2021;11(8):3595–606.
16. Mamede AC, Pires AS, Abrantes AM, Tavares SD, Gonçalves AC, Casalta‐ Lopes JE, et al. Cytotoxicity of ascorbic acid in a human colorectal adenocarcinoma cell line (WiDr): in vitro and in vivo studies. Nutr Cancer. 2012;64(7):1049–57.
17. Nakanishi K, Hiramoto K, Ooi K. High‐dose vitamin C exerts its anti‐ cancer effects in a Xenograft model of Colon Cancer by suppressing angiogenesis. Biol Pharm Bull. 2021;44(6):884–7.
18. Pires AS, Marques CR, Encarnação JC, Abrantes AM, Mamede AC, Laranjo M, et al. Ascorbic acid and colon cancer: an oxidative stimulus to cell death depending on cell profile. Eur J Cell Biol. 2016;95(6–7):208–18.
19. Wang G, Yin T, Wang Y. In vitro and in vivo assessment of high‐dose vitamin C against murine tumors. Exp Ther Med. 2016;12(5):3058–62.
20. Yun J, Mullarky E, Lu C, Bosch KN, Kavalier A, Rivera K, et al. Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by target‐ ing GAPDH. Science (80‐ ). 2015;350(6266):1391–6.
21. Nakanishi K, Hiramoto K, Sato EF, Ooi K. High‐dose vitamin C adminis‐ tration inhibits the invasion and proliferation of melanoma cells in mice ovary. Biol Pharm Bull. 2021;44(1):75–81.
22. Chen XY, Chen Y, Qu CJ, Pan ZH, Qin Y, Zhang X, et al. Vitamin C induces human melanoma A375 cell apoptosis via Bax‐ and Bcl‐2‐mediated mitochondrial pathways. Oncol Lett. 2019;18(4):3880–6.
23. Kang JS, Cho D, Kim Y‐I, Hahm E, Yang Y, Kim D, et al. L‐ascorbic acid (vitamin C) induces the apoptosis of B16 murine melanoma cells via a caspase‐8?Independent pathway. Cancer Immunol Immunother. 2003;52(11):693–8.
24. Mustafi S, Sant DW, Liu Z‐J, Wang G. Ascorbate induces apoptosis in melanoma cells by suppressing Clusterin expression. Sci Rep. 2017;7(1):3671.
25. Serrano OK, Parrow NL, Violet P‐C, Yang J, Zornjak J, Basseville A, et al. Antitumor effect of pharmacologic ascorbate in the B16 murine mela‐ noma model. Free Radic Biol Med. 2015;87:193–203.
26. Du J, Martin SM, Levine M, Wagner BA, Buettner GR, Wang S, et al. Mechanisms of Ascorbate‐induced cytotoxicity in pancreatic Cancer. Clin Cancer Res. 2010;16(2):509–20.
27. Pollard HB, Levine MA, Eidelman O, Pollard M. Pharmacological ascorbic acid suppresses syngeneic tumor growth and metastases in hormone‐ refractory prostate cancer. In Vivo. 2010;24(3):249–55.
28. Li Z, He P, Luo G, Shi X, Yuan G, Zhang B, et al. Increased Tumoral micro‐ environmental pH improves cytotoxic effect of pharmacologic ascorbic acid in castration‐resistant prostate Cancer cells. Front Pharmacol. 2020;11:570939.
29. Chen P, Yu J, Chalmers B, Drisko J, Yang J, Li B, et al. Pharmacologi‐ cal ascorbate induces cytotoxicity in prostate cancer cells through ATP depletion and induction of autophagy. Anti‐Cancer Drugs. 2012;23(4):437–44.
30. Ramezankhani B, Taha MF, Javeri A. Vitamin C counteracts miR‐302/367‐in‐ duced reprogramming of human breast cancer cells and restores their invasive and proliferative capacity. J Cell Physiol. 2019;234(3):2672–82.
31. Xu Y, Guo X, Wang G, Zhou C. Vitamin C inhibits metastasis of peritoneal tumors by preventing spheroid formation in ID8 murine epithelial peritoneal Cancer model. Front Pharmacol. 2020;11:645.
32. Gregoraszczuk EL, Zajda K, Tekla J, Respekta N, Zdybał P, Such A. Vitamin C supplementation had no side effect in non‐cancer, but had antican‐ cer properties in ovarian cancer cells. Int J Vitam Nutr Res. 2020;3:1–11.
33. Lv H, Wang C, Fang T, Li T, Lv G, Han Q, et al. Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT‐2. npj Precis Oncol. 2018;2(1):1.
34. Alyoussef A, Al‐Gayyar MMH. Cytotoxic and partial hepatoprotective activity of sodium ascorbate against hepatocellular carcinoma through inhibition of sulfatase‐2 in vivo and in vitro. Biomed Pharmacother. 2018;103:362–72.
35. Volta V, Ranzato E, Martinotti S, Gallo S, Russo MV, Mutti L, et al. Preclini‐ cal Demonstration of Synergistic Active Nutrients/Drug (AND) Com‐ bination as a Potential Treatment for Malignant Pleural Mesothelioma. McCormick DL, editor. PLoS One. 2013;8(3):e58051.
36. Ranzato E, Biffo S, Burlando B. Selective Ascorbate toxicity in malignant mesothelioma. Am J Respir Cell Mol Biol. 2011;44(1):108–17.
37. Su X, Shen Z, Yang Q, Sui F, Pu J, Ma J, et al. Vitamin C kills thyroid cancer cells through ROS‐dependent inhibition
of MAPK/ERK and PI3K/AKT pathways via distinct mechanisms. Theranostics. 2019;9(15):4461–73.
38. Tronci L, Serreli G, Piras C, Frau DV, Dettori T, Deiana M, et al. Vitamin C cytotoxicity and its effects in redox homeostasis and energetic metabolism in papillary thyroid carcinoma cell lines. Antioxidants. 2021;10(5):809.
39. Zhou J, Chen C, Chen X, Fei Y, Jiang L, Wang G. Vitamin C promotes apoptosis and cell cycle arrest in Oral squamous cell carcinoma. Front Oncol. 2020;10:976.
40. Deubzer B, Mayer F, Kuçi Z, Niewisch M, Merkel G, Handgretinger R,et al. H2O2‐mediated cytotoxicity of
pharmacologic Ascorbate concen‐ trations to neuroblastoma cells: potential role of lactate and ferritin. Cell Physiol
Biochem. 2010;25(6):767–74.
41. Castro M,Carson G, McConnell M, Herst P. High dose Ascorbate causes both Genotoxic and metabolic stress in Glioma cells. Antioxidants. 2017;6(3):58.
42. Campbell EJ, Dachs GU. Current limitations of murine models in oncol‐ ogy for Ascorbate research. Front Oncol. 2014;4:282.
43. Campbell EJ, Vissers MCM, Wohlrab C, Hicks KO, Strother RM, Bozonet SM, et al. Pharmacokinetic and anti‐ cancer properties of high dose ascorbate in solid tumours of ascorbate‐dependent mice. Free Radic Biol Med. 2016;99:451–62.
44. Chen P, Stone J, Sullivan G, Drisko JA, Chen Q. Anti‐cancer effect of pharmacologic ascorbate and its interaction with supplementary par‐ enteral glutathione in preclinical cancer models. Free Radic Biol Med. 2011;51(3):681–7.
45. Taper HS, Jamison JM, Gilloteaux J, Summers JL, Calderon PB. Inhibition of the development of metastases by dietary vitamin C:K 3 combination. Life Sci. 2004;75(8):955–67.
46. Alessandro Magrì et al: High-dose vitamin C enhances cancer immunotherapy: Sci Transl Med 2020 Feb 26;12(532):eaay8707. doi: 10.1126/scitranslmed.aay8707.
47. Franziska Böttger et al. High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer: J Exp Cain Cancer Res 2021 Oct 30;40(1):343. doi: 10.1186/s13046-021-02134-y.
48. Manuela Giansanti et al: High-Dose Vitamin C: Preclinical Evidence for Tailoring Treatment in Cancer Patients Cancers (Basel) 2021 Mar 20;13(6):1428. doi: 10.3390/cancers13061428.

References for IVC monotherapy in palliative care and quality of life (EOL)
1. Polireddy K, Dong R, Reed G, Yu J, Chen P, Williamson S, et al. High dose parenteral Ascorbate inhibited pancreatic Cancer growth and metasta‐ sis: mechanisms and a phase I/IIa study. Sci Rep. 2017;7(1):17188.
2. Takahashi H, Mizuno H, Yanagisawa A. High‐dose intravenous vitamin C improves quality of life in cancer patients. Pers Med Universe. 2012;1(1):49–53.
3. Vollbracht C, Schneider B, Leendert V, Weiss G, Auerbach L, Beuth J. Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo−/radiotherapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study in Germany. In Vivo. 2011;25(6):983–90.
4. Yeom CH, Jung GC, Song KJ. Changes of terminal Cancer patients’ health‐related quality of life after high dose vitamin C administration. J Korean Med Sci. 2007;22(1):7.